Effects of Synbiotics on FC & Other Contributing Factors

Status Completed

Clinical Trial Summary

Prevalence of functional constipation (FC) was first determined with 15.2% reported. Next, a 16-week randomised, double-blind, placebo-controlled study conducted to assess the improvement in functional constipation among the respective individuals by using synbiotic supplement. Throughout the intervention, it was reported that significant improvements for defecation frequency, Bristol Stool Form (BSF) scale, and Patients Assessment of Constipation Symptoms (PAC-SYM) scores were reported within synbiotic group (p < 0.001). However, no significant different was reported when compared both groups as placebo group was found to have significant within-group difference too. Placebo effect was suspected in this study.

Clinical Trial Description

Digestive system disease is the top ten principal causes of morbidity and mortality among Malaysians whereby functional constipation (FC) is the commonest functional gastrointestinal disorders (FGIDs) reported. Although numerous treatments are available, but over-the-counter drugs which have low product safety and possible toxicity were always given as the treatment option. Synbiotic have been well-studied to improve digestive health includes constipation. Thus, the objectives of this study were to determine the prevalence of FC and to evaluate the effects of synbiotic supplement on improving FC symptoms and contributing factors among constipated individuals in Serdang, Selangor. This study comprised of two parts which were screening and intervention part. The prevalence of functional constipation was relatively high in the study community. Synbiotic supplement was effective in the improvement of functional constipation symptoms, quality of life, and psychological factors. However, the positive improvement in placebo group indicated the existence of placebo effects which led to the improvement in quality of life and changes in psychological factors. Therefore, the current findings are useful information for future intervention in improving functional constipation symptoms. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04620317
Study type	Interventional
Source	Universiti Putra Malaysia
Contact
Status	Completed
Phase	N/A
Start date	January 2015
Completion date	January 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04506801` - The Effect of Probiotics on Functional Constipation in the Elderly	N/A
Completed	`NCT04620161` - A Proof of Concept Study of Pradigastat in Patients With Functional Constipation	Phase 2
Active, not recruiting	`NCT02361749` - Botulinum Toxin Injection Versus Anal Myectomy in Management of Idiopathic Constipation	Phase 4
Completed	`NCT03054805` - The Effect of Probiotics on Constipation, and Intestinal Microflora in Children With Functional Constipation	Phase 4
Not yet recruiting	`NCT01913665` - The Effect of Bifidobacterium Lactis and Inulin on Functional Constipation	N/A
Completed	`NCT01348152` - Effect of TU-100 in Patients With Functional Constipation	Phase 2
Completed	`NCT01622972` - Mode of Action of Moviprep	Phase 4
Completed	`NCT01212146` - Probiotic-enriched Artichoke in Functional Constipation	N/A
Completed	`NCT04231162` - Effect of an 8-week Bifidobacterium Lactis HN019 Supplementation on Functional Constipation	N/A
Not yet recruiting	`NCT03639142` - Dried Plums (Prunes) vs. Polyethylene Glycol 4000 for Treatment of Functional Constipation in Children	Phase 3
Recruiting	`NCT04918329` - Functional Digestive Disorders Observatory
Completed	`NCT02592200` - Effect of Lactobacillus Gasseri DSM 27123 on Functional Constipation in Healthy Women	N/A
Completed	`NCT03707002` - Effect of scFOS on Increase in Stool Frequency in Constipated People	N/A
Recruiting	`NCT06083311` - The Efficacy of a Probiotic for Functional Constipation (FC)	N/A
Completed	`NCT04110145` - Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation	Phase 2
Recruiting	`NCT06196073` - Visceral Osteopathy in Functional Constipation	N/A
Active, not recruiting	`NCT04026113` - Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)	Phase 3
Completed	`NCT02359396` - A Randomized, Open-label, Three-arm Study of MZRW on Tolerability, Exposure and Pharmacokinetics	Phase 1
Completed	`NCT01847950` - Effects of scFOS on Stool Frequency in People With Functionnal Constipation	N/A
Recruiting	`NCT01274793` - Trial for Quantity-Effect Relationship of Acupuncture With Two-ways Regulation to Treat Functional Enteropathy	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of Synbiotics on FC and Other Contributing Factors

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms